Global Cell Therapy Market, Price, Product and Clinical Pipeline Outlook 2024

“Global Cell Therapy Market, Price, Product and Clinical Pipeline Outlook 2024” Report Highlights:

• Market Analysis by Application in Various Therapeutic Areas

• Comprehensive Insight On Clinical Pipeline:  664 Cell Therapies

• Cell Therapy Market Opportunity More Than US$ 25 Billion by 2024

• Marketed Cell Therapies: 21

• Price and Product Insight By Region/Country

• Cell Therapy Clinical Pipeline Overview

• Collaborations and Acquisition in the Cell Therapy Segment

• Regional Analysis of the Cell Therapy Market

Cont For Sample: neeraj@kuickresearch.com

Download Report:

https://www.kuickresearch.com/report-global-cell-therapy-market,-price,-product-and-clinical-pipeline-outlook-2024.php

Cell therapy is an integral part of immunotherapy that has shown excellent therapeutic ability in several clinical indications. In recent years, studies regarding the use of cells for their therapeutic ability have gained immense popularity in the scientific and healthcare research community. The segment currently flourishes with several techniques like CAR-T cell therapy, Stem cell therapy, and cord blood cell therapy with each of them gaining extreme popularity due to their wide application in several clinical indications such as cancer, cardiovascular disease and cancer.

The most popular and common technique of cell therapy aims at using healthy cells from a compatible donor (Allogeneic) or from the patient itself (Autogenic) and their modification to amplify their therapeutic ability. It involves complex steps like genetic screening of cell, modification of cell by genetic sequencing, their harvesting and reinfusion into the patient’s body. Each of these steps plays a vital role in the therapeutic outcome, thus leading to the establishment of the cell therapy market.

Stem cell therapy is currently the dominant segment in the cell therapy market with maximum success rate reported globally. Their special ability to differentiate into any type of cell without losing their identity makes them the most promising therapeutic entities of the future. Researchers claim that stem cells are bound to revolutionize regenerative medicine with it being applied in the treatment of complex disease such as cardiovascular disease, neurodegenerative disease, inflammatory disease and cancer.

1. Prologue to Cell Therapy

  1.1 An Overview to Cells and Their Therapeutic Ability

  1.2 Unique Features of Cellular Therapeutics

    1.2.1 Stem Cells – Key Agents of Cellular Based Therapeutics

    1.2.2 Key Advantages of Cell Therapy over Other Existing Therapeutics

2. Mechanism of Cell Therapy Treatment

  2.1 Principle of Cell Therapy

    2.1.1 Cell Therapy and the Immune Response

    2.1.2 Mechanism of Regenerative Cell Therapy

  2.2 Role of Surface Markers and Their Targeting

    2.2.1 Targeting the Signal Cascades

    2.2.2 Targeting the Microenvironment

  2.3 Allogeneic Stem Cell Therapy

  2.4 Autologous Stem Cell Therapy

3. Stem Cells – Their Application and Contribution in the Establishment of Cell Therapy Market

  3.1 Origin of Stem Cells

    3.1.1 Embryonic Stem Cells

    3.1.2 Adult Stem Cells

    3.1.3 Induced Pluripotent Stem Cells (iPSCs)

  3.2 Exploring Stem Cell’s Ability to Differentiate

    3.2.1 Totipotent Stem Cells

    3.2.2 Pluripotent Stem Cells

    3.2.3 Multipotent Stem Cells

    3.2.4 Unipotent Stem Cells

4. Cell Therapy Market Analysis by Application in Various Therapeutic Areas

  4.1 Cell Therapy for Cardiovascular Disease

    4.1.1 Myocardial Infarction

    4.1.2 Heart Failure

  4.2 Cell Therapy for Neurological Disorders

    4.2.1 Parkinson’s Diseases

    4.2.2 Alzheimer’s Diseases

    4.2.3 Huntington’s Diseases

  4.3 Cell Therapy for Inflammatory Diseases

    4.3.1 Asthma

    4.3.2 Arthritis

  4.3 Cell Therapy for Diabetes

    4.3.3 Type 1 diabetes

    4.3.4 Type 2 diabetes

  4.4 Cell Therapy for Cancer

    4.4.1 Stem Cells and Their Therapeutic Role in Cancer

    4.4.2 Role of Surface Markers and Their Targeting

    4.4.3 Targeting the Signal Cascades

    4.4.4 Targeting the Microenvironment

5. Product and Price Analysis of Cell Therapy Approved in US

  5.1 Apligraf and Dermagraft

  5.2 Carticel

  5.3 ChondroCelect

  5.4 Epicel

  5.5 Holoclar

  5.6 Kymriah

  5.7 Provenge

  5.8 Yescarta

6. Product and Price Analysis of Cell Therapy Products Approved in Europe

  6.1 Spherox

  6.2 Strimvelis

7. Product and Price Analysis of Cell Therapy Approved in South Korea

  7.1 Cartistem

  7.2 Cupistem

  7.3 Hearticellgram

8. Product and Price Analysis of Cell Therapy Approved in Japan

  8.1 HeartSheet

  8.2 Temcell

9. Current Status of the Global Cell Therapy Market

  9.1 Overview of the Global Cell Therapy Market

  9.2 Industrial Insight into the Cell Therapy Market – Key Players and Their Contribution

  9.3 Cell Therapy Clinical Pipeline Overview

  9.4 Investments in the Cell Therapy Market

10. Global Cell Therapy Market Trends

  10.1 Cell Therapy Enhancing the Effect of Existing Therapeutic Methods

  10.2 Cell Therapy Market More Oriented Towards Immune Cells

  10.3 Involvement of Both Academia and Industries to Enhance Progress of Cell Therapy Studies

  10.4 Impact of Cell Therapy on the Drug Delivery Market

    10.4.1 Direct Delivery Methods

    10.4.2 Indirect Delivery Method

11. Collaborations and Acquisition in the Cell Therapy Segment

  11.1 Collaborations

  11.2 Acquisition

12. Regional Analysis of the Cell Therapy Market

  12.1 North America

  12.2 Europe

  12.3 Asia

    12.3.1 China

    12.3.2 Japan

    12.3.3 South Korea

    12.3.4 India

  12.4 Rest of the World

    12.4.1 Africa

    12.4.2 Middle East

    12.4.3 South America

13. Global Cell Therapy Market Dynamics

  13.1 Growth Promoting Parameters of the Cell Therapy Market

  13.2 Commercial Challenges of the Cell Therapy Market

14. Future Prospectus and Scope of the Cell Therapy Market

15. Global Cell Therapy Clinical Pipeline by Company, Indication and Phase

  15.1 Unknown

  15.2 Research

  15.3 Preclinical

  15.4 Clinical

  15.5 Phase-0

  15.6 Phase-I

  15.7 Phase-I/II

  15.8 Phase-II

  15.9 Phase-II/III

  15.10 Phase-III

  15.11 Preregistration

  15.12 Registered

16. Marketed Cell Therapy Clinical Insight

  16.1 Immuncell-LC

  16.2 Adipocell (Anterogen)

  16.3 Provenge

  16.4 CureXcell

  16.5 Holoclar

  16.6 MACI

  16.7 Carticel

  16.8 MyoCell

  16.9 Laviv

  16.10 Prochymal

  16.11 Grafix

  16.12 Gintuit

  16.13 Autologous Mesenchymal Stem Cell Therapy – Pharmicell

  16.14 Cartistem

  16.15 CHONDRON

  16.16 BioCart

  16.17 NuCel

  16.18 Dendritic Cell-Activated Cytokine-Induced Killer Cells

  16.19 Chondrotransplant DISC

  16.20 Urocell

  16.21 CellSpray

17. Competitive Landscape

  17.1 AlloCure

  17.2 Arteriocyte Medical Systems

  17.3 Athersys Inc.

  17.4 Baxter Healthcare Corporation

  17.5 Bone Therapeutics

  17.6 Celgene Corporation

  17.7 Cell Medica

  17.8 Cellerant Therapeutics

  17.9 FibrocellScinence

  17.10 Forticell Bioscience

  17.11 Genzyme Corporation

  17.12 Green Cross Cell

  17.13 Histogenics Corporation

  17.14 InnovacellBiotechnologie AG

  17.15 Intrexon Corporation

  17.16 Intercytex

  17.17 ISTO Technologies

  17.18 Macrocure

  17.19 Mesoblast

  17.20 Molmed

  17.21 Nuo Therapeutics Inc

  17.22 OmniCyte

  17.23 Opexa Therapeutics

  17.24 Organogenesis

  17.25 Pharmicell

  17.26 TCA Cellular Therapy

  17.27 Stem Cell Inc.

  17.28 Teva Pharmaceuticals

  17.29 Tigenix

  17.30 Vericel Corporation